Literature DB >> 8556379

Opportunistic osteomyelitis in the jaws of children on immunosuppressive chemotherapy.

L Hovi1, U M Saarinen, U Donner, C Lindqvist.   

Abstract

PURPOSE: Four children with an osteomyelitic process in the jaw bones while on cytotoxic chemotherapy were treated by radical surgery and antimicrobial chemotherapy. PATIENTS AND METHODS: Symptoms (local swelling and pain in the jaw, necrotic gingivitis, and spontaneous loss of teeth) appeared 3 weeks, 4 weeks, and 8 months after diagnosis of leukemia, and 8 days posttransplant in a patient with severe aplastic anemia. Three had the process in the mandible and one in the maxilla. Specific diagnoses of Aspergillus flavus, Saccharomyces cerevisiae, and Actinomyces species were obtained histologically from surgical samples. Treatment was radical surgery to remove all infected and necrotic tissue: removal of a substantial part of the mandible and loss of seven to eight permanent teeth in those with mandibular lesions. Actinomycosis was treated with penicillin for 2 years. The patients with fungal lesions received amphotericin B for 2, 5, and 6 months, with adjuvant itraconazole, fluconazole, or 5-fluorocytosine for 9-12 months. Anti-cancer chemotherapy was continued.
RESULTS: All the bony lesions healed. The patient with acute myeloid leukemia died in relapse 1 year postdiagnosis; her aspergillus osteomyelitis had been inactive for 8 months. The other three patients are alive and well 1.9, 2.1, and 1.9 years after termination of antimicrobial therapy.
CONCLUSIONS: We emphasize the necessity of specific diagnosis from appropriate surgical samples and conclude that in patients undergoing chemotherapy bony lesions caused by opportunistic microorganisms may be curable with aggressive surgery and prolonged medication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8556379     DOI: 10.1097/00043426-199602000-00018

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  7 in total

Review 1.  Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome.

Authors:  Maria N Gamaletsou; Blandine Rammaert; Marimelle A Bueno; Brad Moriyama; Nikolaos V Sipsas; Dimitrios P Kontoyiannis; Emmanuel Roilides; Valerie Zeller; Roberta Prinapori; Saad J Taj-Aldeen; Barry Brause; Olivier Lortholary; Thomas J Walsh
Journal:  J Infect       Date:  2013-12-27       Impact factor: 6.072

2.  Actinomycotic Osteomyelitis of the Maxilla in a Patient on Phenytoin.

Authors:  Farzaneh Aghahosseini; Elaheh Ghasemzadeh Hoseini; Nazanin Mahdavi
Journal:  Front Dent       Date:  2022-01-15

3.  Actinomycosis of the jaws--histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis.

Authors:  Torsten Hansen; Martin Kunkel; Erik Springer; Christian Walter; Achim Weber; Ekkehard Siegel; C James Kirkpatrick
Journal:  Virchows Arch       Date:  2007-10-20       Impact factor: 4.064

4.  Osteomyelitis of maxilla in poorly controlled diabetics in a rural Indian population.

Authors:  Ranjit Kumar Peravali; Bhushan Jayade; Abhijit Joshi; Mahantesh Shirganvi; C Bhasker Rao; K Gopalkrishnan
Journal:  J Maxillofac Oral Surg       Date:  2011-10-02

Review 5.  Invasive aspergillosis in children with hematologic malignancies.

Authors:  Rashed A Hasan; Walid Abuhammour
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

6.  Saccharomyces cerevisiae osteomyelitis in an immunocompetent baker.

Authors:  Piseth Seng; Alexandre Cerlier; Carole Cassagne; Mathieu Coulange; Regis Legré; Andreas Stein
Journal:  IDCases       Date:  2016-05-19

7.  Craniofacial Actinomyces osteomyelitis evolving from sinusitis.

Authors:  Joseph Y Shen; Neal D Futran; Maya G Sardesai
Journal:  Radiol Case Rep       Date:  2017-12-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.